Return to homepagePandemic Pact

Risk factors, personalized prognosis and one-year follow-up of patients admitted to the Spanish Intensive Care Units infected by the COVID virus: CIBERSESUCICOVID

  • Funded by National Institute of Health Carlos III [El Instituto de Salud Carlos III] (ISCIII)
  • Total publications:0 publications

Grant number: COV20_00110

Grant search

Key facts

  • Disease

    COVID-19

  • Funder

    National Institute of Health Carlos III [El Instituto de Salud Carlos III] (ISCIII)

  • Principal Investigator

    Antoni Torre Martí

  • Research Location

    Spain

  • Lead Research Institution

    CONSORCIO CENTRO DE INVESTIGACION BIOMEDICA EN RED (CIBER)

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Prognostic factors for disease severity

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The project presented has the objective of knowing the risk factors and prognosis and short and long-term outcomes (6 months and one year) of patients with COVID19 admitted to Spanish ICUs. Two other additional objectives are the epigenetic study and essential predictive enrichment biomarkers to help individualize treatment based on the altered biological pathways in each patient. CIBERES has the endorsement of SEMICYUC and SEPAR. The hypothesis at the end of the pandemic that 10,000 patients will have been admitted to the Spanish ICUs selected through SEPAR and SEMICYUC. The clinical data will be analyzed with artificial intelligence. An interim analysis will be made with the first 1000 patients, which may be useful for the clinical management of patients with severe COVID19.